Compare Estee Lauder Companies Inc (EL) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Estee Lauder Companies Inc vs Health Care Select Sector SPDR Fund — how do they compare? Estee Lauder Companies Inc trades at $98.23 (market cap $34.17B), while Health Care Select Sector SPDR Fund trades at $170.79 (market cap $43.48B). The key difference: Health Care Select Sector SPDR Fund is the larger of the two by market cap, and Estee Lauder Companies Inc pays a 1.48% dividend while Health Care Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold Estee Lauder Companies Inc for 122 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| EL | XLV | |
|---|---|---|
Market Cap | $34.17B | $43.48B |
Volume | 3,921,497 | 11,121,431 |
Sector | Consumer Staples | — |
52-Week High | $119.61 | $175.68 |
52-Week Low | $67.23 | $141.95 |
Typical Hold Time | 122 Days | 100 Days |
Enterprise Value | $39.92B | — |
Dividend Yield | 1.48% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Estée Lauder (EL) trades at $98.05, up 3.81% today, with a neutral technical signal and bullish moving averages. The stock has beaten earnings estimates for three consecutive quarters, though it reported a net loss of $1.13 billion in 2025. Analyst consensus is a Buy with a $103.00 price target, and recent news highlights strategic partnerships in AI and leadership changes.
The outlook is mixed: strong gross margins and recent earnings beats support upside, but high valuation ratios and negative net income pose risks. Investor sentiment is cautiously optimistic, driven by digital initiatives and brand strategy, yet competitive pressures and macroeconomic headwinds remain key concerns for sustained growth.
XLV trades at $170.86, up 1.21% with a bearish technical signal from moving averages while oscillators remain neutral. The healthcare ETF shows strong cost advantages with a 0.08% expense ratio compared to peers, holding 61 diversified healthcare stocks from the S&P 500. Recent news highlights XLV's defensive characteristics during potential Fed rate hikes and political volatility.
The ETF offers defensive exposure to healthcare with low costs, though technical indicators suggest near-term pressure. Key risks include sector-specific regulatory changes and election uncertainty, while the fund's diversification provides stability amid market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Estee Lauder Companies Inc
Estee Lauder is the world leader in the global prestige beauty market, participating across skincare (56% of fiscal 2022 sales), makeup (26%), fragrance (14%), and haircare (4%) categories, with popular brands such as Estee Lauder, Clinique, MAC, La Mer, Jo Malone, Aveda, Bobbi Brown, Too Faced, Origins, Dr. Jart+, and The Ordinary. The firm operates in 150 countries, with 26% of fiscal 2022 revenue stemming from the Americas, 43% from Europe, the Middle East, and Africa, and 31% from Asia-Pacific. The company sells its products through department stores, travel retail, multi-brand specialty beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.
Read more on EL →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
